Clinical Trials Logo

Healthy Adult Volunteers clinical trials

View clinical trials related to Healthy Adult Volunteers.

Filter by:

NCT ID: NCT03748758 Completed - Clinical trials for Healthy Adult Volunteers

Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers

Start date: November 27, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability of two dose levels of OP0201 and placebo, when administered intranasally in healthy adults subjects.

NCT ID: NCT02942771 Completed - Clinical trials for Healthy Adult Volunteers

A MAD Study of TT301/MW189 in Healthy Volunteers

Start date: March 20, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this Study is to find out whether an investigational drug is safe and well tolerated. MW189 is being studied as a possible short-term treatment for people with different types of brain injury. MW189 has previously been given to healthy human volunteers as a single dose, and there were no significant problems or bad effects in people who received the Study drug. However, before it can be tested in people with brain injury, it is important to test MW189 in healthy volunteers when given multiple doses.

NCT ID: NCT02822898 Completed - Clinical trials for Healthy Adult Volunteers

Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults

MIHMoSA
Start date: June 2016
Phase: Phase 4
Study type: Interventional

The prescription of intravenous maintenance solutions - although widespread - lacks important data on the optimal sodium and potassium content, which has given rise to an important debate in the scientific literature. Our study compares two different infusion fluids in 12 healthy adult volunteers without renal failure in a single-blind randomized crossover design over two 48 hour periods during which subjects are not allowed to eat or drink. Fluid 1 is a premixed solution containing 54 mmol/L of sodium and 26 mmol/L of potassium; fluid 2 is sodium chloride 0.9% in glucose 5% with 40 mmol/L of potassium. Both solutions are administered at 25 mL/kg of ideal body weight, as recommended by current guidelines (NICE 174) and both solutions are widely used in daily clinical practice. The primary hypothesis is that isotonic maintenance solutions lead to more fluid retention than hypotonic fluids. Metabolism of both solutions is assessed by sequential analysis of urine and serum, clinical parameters and bioelectrical impedance analysis.

NCT ID: NCT02208882 Completed - Clinical trials for Healthy Adult Volunteers

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120

Start date: August 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and effect on Midazolam pharmacokinetics of multiple oral doses of BMS-986120 in healthy subjects.

NCT ID: NCT02182609 Completed - Clinical trials for Healthy Adult Volunteers

99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers

Start date: April 2013
Phase: Phase 1
Study type: Interventional

The objectives of this study are: - To determine the safety and tolerability of a single dose of 99mTc-rhAnnexin V-128 administered as an intravenous bolus over 10-20 seconds. - To determine the biodistribution, pharmacokinetics and radiation dosimetry of 99mTc-rhAnnexin V-128 in normal healthy adult volunteers.

NCT ID: NCT02079480 Terminated - Clinical trials for Healthy Adult Volunteers

Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Start date: May 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-986090 in healthy subjects.

NCT ID: NCT02058472 Active, not recruiting - Clinical trials for Healthy Adult Volunteers

Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers

Start date: December 2013
Phase: Phase 1
Study type: Interventional

Study Design : randomized, open label, single-dose, 2-way cross-over design Phase : Phase I

NCT ID: NCT01672242 Completed - Clinical trials for Healthy Adult Volunteers

Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)

Start date: July 2012
Phase: N/A
Study type: Interventional

Respiratory distress is a common problem in an intensive care unit. There are multiple mechanisms that are used to help patients who are in respiratory distress including mechanical ventilation, continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), high flow oxygen, and oxygen supplementation through nasal cannula or a facemask. The purpose of this study is to evaluate the mechanism by which Vapotherm, a high flow oxygen system, provides breathing support. Vapotherm provides high flow oxygen at different flow rates, meaning one can increase the amount of oxygen flow to help with breathing support. The investigators believe that this high flow oxygen system may provide similar breathing support that a continuous positive airway pressure machine (CPAP) machine does.

NCT ID: NCT01657838 Completed - Clinical trials for Healthy Adult Volunteers

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects

Start date: May 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of ketoconazole at steady state on the pharmacokinetics of a single dose of isavuconazole in healthy adult subjects.

NCT ID: NCT01651325 Completed - Clinical trials for Healthy Adult Volunteers

Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects

Start date: May 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of a single dose of dextromethorphan in healthy adult subjects.